Literature DB >> 10713147

Distinct mitochondrial and cytosolic enzymes mediate trypanothione-dependent peroxide metabolism in Trypanosoma cruzi.

S R Wilkinson1, N J Temperton, A Mondragon, J M Kelly.   

Abstract

The American trypanosome Trypanosoma cruzi is exposed to toxic oxygen metabolites that are generated by drug metabolism and immune responses in addition to those produced by endogenous processes. However, much remains to be resolved about the parasite oxidative defense system, including the mechanism(s) of peroxide reduction. Here we show that reduction of peroxides in T. cruzi is catalyzed by two distinct trypanothione-dependent enzymes. These were localized to the cytosol and mitochondrion. Both are members of the peroxiredoxin family of antioxidant proteins and are characterized by the presence of two conserved domains containing redox active cysteines. The role of these proteins in protecting T. cruzi from peroxide-mediated damage was demonstrated following overexpression of enzyme activity. The parasite-specific features of T. cruzi cytoplasmic peroxiredoxin and T. cruzi mitochondrial peroxiredoxin may be exploitable in terms of drug development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713147     DOI: 10.1074/jbc.275.11.8220

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Peroxiredoxins in parasites.

Authors:  Michael C Gretes; Leslie B Poole; P Andrew Karplus
Journal:  Antioxid Redox Signal       Date:  2012-01-25       Impact factor: 8.401

2.  Intraphagosomal peroxynitrite as a macrophage-derived cytotoxin against internalized Trypanosoma cruzi: consequences for oxidative killing and role of microbial peroxiredoxins in infectivity.

Authors:  María Noel Alvarez; Gonzalo Peluffo; Lucía Piacenza; Rafael Radi
Journal:  J Biol Chem       Date:  2010-11-23       Impact factor: 5.157

3.  The metabolism of S-nitrosothiols in the trypanosomatids: the role of ovothiol A and trypanothione.

Authors:  Ryan N Vogt; Daniel J Steenkamp
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

4.  Role of Trypanosoma cruzi peroxiredoxins in mitochondrial bioenergetics.

Authors:  Eduardo de Figueiredo Peloso; Simone Cespedes Vitor; Luis Henrique Gonzaga Ribeiro; María Dolores Piñeyro; Carlos Robello; Fernanda Ramos Gadelha
Journal:  J Bioenerg Biomembr       Date:  2011-07-06       Impact factor: 2.945

5.  Expression of a mitochondrial peroxiredoxin prevents programmed cell death in Leishmania donovani.

Authors:  Simone Harder; Meike Bente; Kerstin Isermann; Iris Bruchhaus
Journal:  Eukaryot Cell       Date:  2006-05

6.  Synthesis and evaluation of the antileishmanial activity of silver compounds containing imidazolidine-2-thione.

Authors:  Patrícia Ferreira Espuri; Larissa Luiza Dos Reis; Eduardo de Figueiredo Peloso; Vanessa Silva Gontijo; Fábio Antônio Colombo; Juliana Barbosa Nunes; Carine Ervolino de Oliveira; Eduardo T De Almeida; Débora E S Silva; Jessica Bortoletto; Daniel Fonseca Segura; Adelino V G Netto; Marcos José Marques
Journal:  J Biol Inorg Chem       Date:  2019-04-04       Impact factor: 3.358

7.  Biochemical characterization of a trypanosome enzyme with glutathione-dependent peroxidase activity.

Authors:  S R Wilkinson; D J Meyer; J M Kelly
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

Review 8.  Redox metabolism in mitochondria of trypanosomatids.

Authors:  Ana M Tomás; Helena Castro
Journal:  Antioxid Redox Signal       Date:  2012-11-15       Impact factor: 8.401

9.  Redox potential regulates binding of universal minicircle sequence binding protein at the kinetoplast DNA replication origin.

Authors:  Itay Onn; Neta Milman-Shtepel; Joseph Shlomai
Journal:  Eukaryot Cell       Date:  2004-04

10.  Peroxiredoxins play a major role in protecting Trypanosoma cruzi against macrophage- and endogenously-derived peroxynitrite.

Authors:  Lucía Piacenza; Gonzalo Peluffo; María Noel Alvarez; John M Kelly; Shane R Wilkinson; Rafael Radi
Journal:  Biochem J       Date:  2008-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.